Answers are grounded in this paper and cite their sources.
The synthesis of three substituted 6,7-dihydroxy-4-quinazolineamines: tandutinib (1), erlotinib (2) and gefitinib (3) in improved yields is reported. The intermediates were characterized by NMR and the purities determined by HPLC.
No takes yet. Share an insight, caveat, or question.
Knesl et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: